Showing results (721-730 of 742) with videos related to

Sort By:
Pageof 75
Journal of Virus Eradication|November 30, 2020
A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infectionEugène D M B Kroon, Jintanat Ananworanich, Amélie Pagliuzza, et al.
Plos Pathogens|August 22, 2024
Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistenceBenjamin Varco-Merth, Morgan Chaunzwa, Derick M Duell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2017
Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected IndividualsKersten K Koelsch, Thomas A Rasmussen, William J Hey-Nguyen, et al.
Ebiomedicine|February 28, 2021
A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controlsJames H McMahon, Jennifer M Zerbato, Jillian S Y Lau, et al.
BMJ Global Health|October 23, 2024
Oral varespladib for the treatment of snakebite envenoming in India and the USA (BRAVO): a phase II randomised clinical trialCharles J Gerardo, Rebecca W Carter, Surendra Kumar, et al.
Annals of the American Thoracic Society|June 26, 2026
Deployment-Related Respiratory Health: Bridging the Gap between Clinical and Epidemiological Associations and Disease Mechanisms An Official American Thoracic Society Workshop ReportBradley W Richmond, Barrak Alahmad, Coleen P Baird, et al.
Nature Reviews. Immunology|July 21, 2012
Towards an HIV cure: a global scientific strategy, Steven G Deeks, Brigitte Autran, et al.
Nature Communications|February 2, 2019
The antimicrobial potential of Streptomyces from insect microbiomesMarc G Chevrette, Caitlin M Carlson, Humberto E Ortega, et al.
The Lancet. HIV|February 26, 2026
Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research TrialsThumbi Ndung'u, Krista L Dong, Donn J Colby, et al.
Nature Medicine|September 11, 2023
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trialJesper D Gunst, Jesper F Højen, Marie H Pahus, et al.
Pageof 75